Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALEXANDER Y KIM

Allopathic & Osteopathic Physicians Radiology Vascular & Interventional Radiology

NPI
1215183991
CMS profile
9137
Location
OXON HILL, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$308,518.19

139 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
TriSalus Life Sciences, Inc. $253,641.17 58
Sirtex Medical Inc $36,664.02 68
Siemens Medical Solutions USA, Inc. $18,159.52 11
Medtronic, Inc. $28.80 1
Boston Scientific Corporation $24.68 1

Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALEXANDER Y KIM

NPI 1215183991 · CMS profile ID 9137

Allopathic & Osteopathic Physicians / Radiology / Vascular & Interventional Radiology

OXON HILL, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1215183991?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALEXANDER Y KIM, NPI 1215183991, CMS profile ID 9137. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1215183991?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ALEXANDER Y KIM, NPI 1215183991, CMS profile ID 9137. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1215183991?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ALEXANDER Y KIM, NPI 1215183991, CMS profile ID 9137, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1215183991?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

139 matching records · $308,518.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 139 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–139 of 139.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
TriSalus Life Sciences, Inc. $22,050.0005/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079463 CMS
TriSalus Life Sciences, Inc. $248.0805/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079469 CMS
Sirtex Medical Inc $25.5005/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032407047 CMS
TriSalus Life Sciences, Inc. $631.8005/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079453 CMS
TriSalus Life Sciences, Inc. $143.3504/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079447 CMS
TriSalus Life Sciences, Inc. $57.9404/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079441 CMS
TriSalus Life Sciences, Inc. $164.7304/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079437 CMS
TriSalus Life Sciences, Inc. $43.0004/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079431 CMS
Siemens Medical Solutions USA, Inc. $134.2704/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987565427 CMS
TriSalus Life Sciences, Inc. $2.0604/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079425 CMS
TriSalus Life Sciences, Inc. $59.9104/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079419 CMS
TriSalus Life Sciences, Inc. $35,325.0004/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079407 CMS
TriSalus Life Sciences, Inc. $1,557.3804/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079411 CMS
TriSalus Life Sciences, Inc. $127.2703/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079401 CMS
TriSalus Life Sciences, Inc. $21.7603/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079395 CMS
TriSalus Life Sciences, Inc. $1,847.8003/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079391 CMS
TriSalus Life Sciences, Inc. $860.8003/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079385 CMS
TriSalus Life Sciences, Inc. $900.8003/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079379 CMS
TriSalus Life Sciences, Inc. $11.5603/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079369 CMS
TriSalus Life Sciences, Inc. $28.9903/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079375 CMS
TriSalus Life Sciences, Inc. $16.0603/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079347 CMS
TriSalus Life Sciences, Inc. $136.8403/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079353 CMS
TriSalus Life Sciences, Inc. $27.5703/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079359 CMS
TriSalus Life Sciences, Inc. $224.8803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079363 CMS
TriSalus Life Sciences, Inc. $13.3703/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079343 CMS
TriSalus Life Sciences, Inc. $21,375.0003/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079331 CMS
TriSalus Life Sciences, Inc. $579.4203/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079337 CMS
TriSalus Life Sciences, Inc. $183.6703/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079321 CMS
TriSalus Life Sciences, Inc. $17.3203/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079327 CMS
TriSalus Life Sciences, Inc. $26,970.9102/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079311 CMS
TriSalus Life Sciences, Inc. $108.2702/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079317 CMS
TriSalus Life Sciences, Inc. $13,725.0002/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079299 CMS
TriSalus Life Sciences, Inc. $249.5302/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079305 CMS
Siemens Medical Solutions USA, Inc. $253.2302/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987565423 CMS
TriSalus Life Sciences, Inc. $52.1601/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079295 CMS
TriSalus Life Sciences, Inc. $113.9201/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079289 CMS
TriSalus Life Sciences, Inc. $91.0101/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079281 CMS
TriSalus Life Sciences, Inc. $610.7901/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079271 CMS
TriSalus Life Sciences, Inc. $438.9401/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055079278 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $66,193.36 111
PY2020 $119,204.56 208
PY2021 $219,482.08 323
PY2022 $353,688.13 238
PY2023 $308,518.19 139
PY2024 $156.09 6
PY2025 $20,374.55 41

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $32,731.84 15
PY2020 Principal investigator $76,285.00 8
PY2019 Principal investigator $15,714.00 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $38.80 12/31/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY MEDICAL CENTER MEMORY DISORDERS PROGRAM
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826448983
Principal investigator 1 AstraZeneca Pharmaceuticals LP $301.80 12/31/2021 Non-covered Recipient Entity
GEORGETOWN UNIV
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826464673
Principal investigator 1 AstraZeneca Pharmaceuticals LP $621.84 12/31/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY MEDICAL CENTER
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826481091
Principal investigator 1 AstraZeneca Pharmaceuticals LP $829.12 12/31/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826483595
Principal investigator 1 AstraZeneca Pharmaceuticals LP $207.28 12/31/2021 Non-covered Recipient Entity
BREAST CANCER SYMPOSIUM
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826484240
Principal investigator 1 Merit Medical Systems Inc $450.00 06/30/2021 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer No dispute reported 06/30/2026 830890617
Principal investigator 1 Merit Medical Systems Inc $1,375.00 05/05/2021 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer No dispute reported 06/30/2026 830890615
Principal investigator 1 Sirtex Medical Inc $2,200.00 05/01/2021 Covered Recipient Teaching Hospital
Georgetown University Hospital
Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study No dispute reported 06/30/2026 855363045
Principal investigator 1 Sirtex Medical Inc $1,000.00 05/01/2021 Covered Recipient Teaching Hospital
Georgetown University Hospital
Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study No dispute reported 06/30/2026 855363047
Principal investigator 1 TriSalus Life Sciences, Inc. $1,600.00 03/31/2021 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
IRB Review No dispute reported 06/30/2026 852084957
Principal investigator 1 AstraZeneca Pharmaceuticals LP $3,640.00 03/17/2021 Non-covered Recipient Entity
GEORGETOWN UNIV
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826450705
Principal investigator 1 AstraZeneca Pharmaceuticals LP $10,000.00 03/17/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826450841
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,500.00 03/17/2021 Non-covered Recipient Entity
BREAST CANCER SYMPOSIUM
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826459661
Principal investigator 1 AstraZeneca Pharmaceuticals LP $468.00 03/17/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY MEDICAL CENTER MEMORY DISORDERS PROGRAM
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826462793
Principal investigator 1 AstraZeneca Pharmaceuticals LP $7,500.00 03/17/2021 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY MEDICAL CENTER
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma No dispute reported 06/30/2026 826465797